Vericel Corporation (NASDAQ:VCEL) Sellers Declined Their Shorts By 20.59% As Of May 3, 2018

May 3, 2018 - By Maria Fierro

Vericel Corporation (NASDAQ:VCEL) Corporate Logo

Vericel Corporation (NASDAQ:VCEL) had a decrease of its short interest by 20.59%. FINRA issued short interest of VCEL’s total 1.07M shares. The 1.35M previous shares are down with 20.59%. Vericel Corporation (NASDAQ:VCEL) has 804,200 shares average volume. It’ll cost 1 days for VCEL to restore its previous position. 3.77% is Vericel Corporation float short.

Ticker’s shares touched $12.7928 during the last trading session after 1.97% change.Currently Vericel Corporation is uptrending after 240.35% change in last May 3, 2017. VCEL has also 125,162 shares volume. The stock outperformed the S&P 500 by 228.80%.

Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, makes, markets, and sells patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions.The firm is valued at $466.16 million. It markets three autologous cell therapy products, including Carticel and MACI, which are used for the treatment of cartilage defects in the knee; and Epicel, a permanent skin replacement that is used for the treatment of patients with deep-dermal or full-thickness burns comprising greater than or equal to 30 percent of total body surface area in the United States.Currently it has negative earnings. The firm also develops ixmyelocel-T, which is in Phase IIb clinical trial, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy.

Vericel Corporation (NASDAQ:VCEL) Ratings Coverage

In total 4 analysts cover Vericel Corp (NASDAQ:VCEL). “Buy” rating has 4, “Sell” are 0, while 0 are “Hold”. (NASDAQ:VCEL) has 100% bullish analysts. 7 are the (NASDAQ:VCEL)’s ratings reports on May 3, 2018 according to StockzIntelligence Inc. On Tuesday, January 2 Piper Jaffray maintained the shares of VCEL in report with “Buy” rating. On Monday, March 5 BTIG Research maintained the shares of VCEL in report with “Buy” rating. On Tuesday, November 7 the firm earned “Buy” rating by BTIG Research. On Wednesday, April 4 the stock of Vericel Corporation (NASDAQ:VCEL) has “Buy” rating given by Leerink Swann. On Thursday, April 12 the firm has “Buy” rating by BTIG Research given. On Wednesday, March 28 the company was maintained by BTIG Research.

Vericel Corporation (NASDAQ:VCEL) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: